Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Geron (GERN) EBT (2016 - 2025)

Geron's EBT history spans 16 years, with the latest figure at -$28.8 million for Q4 2025.

  • For Q4 2025, EBT fell 22.02% year-over-year to -$28.8 million; the TTM value through Dec 2025 reached -$83.1 million, up 51.85%, while the annual FY2025 figure was -$83.1 million, 51.85% up from the prior year.
  • EBT for Q4 2025 was -$28.8 million at Geron, down from -$18.3 million in the prior quarter.
  • Across five years, EBT topped out at -$16.3 million in Q2 2025 and bottomed at -$67.3 million in Q2 2024.
  • The 5-year median for EBT is -$29.8 million (2021), against an average of -$35.0 million.
  • The largest annual shift saw EBT plummeted 81.48% in 2021 before it soared 75.77% in 2025.
  • A 5-year view of EBT shows it stood at -$32.0 million in 2021, then plummeted by 33.46% to -$42.7 million in 2022, then decreased by 21.75% to -$52.0 million in 2023, then surged by 54.63% to -$23.6 million in 2024, then fell by 22.02% to -$28.8 million in 2025.
  • Per Business Quant, the three most recent readings for GERN's EBT are -$28.8 million (Q4 2025), -$18.3 million (Q3 2025), and -$16.3 million (Q2 2025).